Contact
searchSearch
HMP Global

Aortic Interventions Topic Center

Features

TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management
Dr Angle
ISET 2025
Managing End-Organ Ischemia in Acute Aortic Dissection
02/04/2025
At ISET 2025 on Tuesday, John Angle, MD, from the University of Virginia, presented a comprehensive discussion on managing end-organ ischemia in patients with acute aortic dissection.
At ISET 2025 on Tuesday, John Angle, MD, from the University of Virginia, presented a comprehensive discussion on managing end-organ ischemia in patients with acute aortic dissection.
At ISET 2025 on Tuesday, John...
02/04/2025
Vascular Disease Management
Chiara Lomazzi and Santi Trimarchi
LINC 2025
10-Year Results of the GREAT Registry: Lessons Learned From More Than 30 Publications
01/29/2025
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara...
01/29/2025
Vascular Disease Management
News
Echo IQ Signs Integration Agreement With Flagship US Hospital
12/12/2024
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the...
12/12/2024
Vascular Disease Management
Bridging Stent for FEVAR
World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation
12/02/2024
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024...
12/02/2024
Vascular Disease Management
News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Gore Minimizing Air
Video
When Used as Recommended, Gore TEVAR Solutions Facilitate a Means for Minimizing Air
11/01/2024
Watch this video to learn more!
Watch this video to learn more!
Watch this video to learn more!
11/01/2024
Vascular Disease Management
Embolic Protection for TAVR
EMBLOK Announces Enrollment of 50th Patient in Clinical Trial for Emblok™ Embolic Protection System for use in TAVR Procedures, Appoints Scientific and Strategic Advisory Board
10/08/2024
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity Tampa, FL – October 8, 2024 – EMBLOK™ (emblok.com), a privately held medical...
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity Tampa, FL – October 8, 2024 – EMBLOK™ (emblok.com), a privately held medical...
Medical device company marks...
10/08/2024
Vascular Disease Management
Dr Henretta
Podcast
Listen as John Henretta, MD, Describes a New Global Aortic Registry, What Is Unique About It, and Why It Matters
10/01/2024
Dr. John Henretta talks about the new Gore Together Aortic Registry.
Dr. John Henretta talks about the new Gore Together Aortic Registry.
Dr. John Henretta talks about...
10/01/2024
Vascular Disease Management

Videos

Gore Minimizing Air
Video
When Used as Recommended, Gore TEVAR Solutions Facilitate a Means for Minimizing Air
11/01/2024
Watch this video to learn more!
Watch this video to learn more!
Watch this video to learn more!
11/01/2024
Vascular Disease Management
AAA Screening
Video
Ross Milner, MD, Discusses Early Detection for AAA and Screening Available for Eligible Patients With U.S. Hockey Legend Jim Craig
09/01/2024
In this video, Dr. Ross Milner talks with hockey legend Jim Craig about abdominal aortic aneurysm screening.
In this video, Dr. Ross Milner talks with hockey legend Jim Craig about abdominal aortic aneurysm screening.
In this video, Dr. Ross Milner...
09/01/2024
Vascular Disease Management
Video
William Jordan, MD, National Principal Investigator, Shares His Views on the Clinical Outcomes 5-year Results From U.S. IDE Clinical Trial for Thoracic Aortic Aneurysms
07/01/2024
Dr. Jordan discusses the 5-year results.
Dr. Jordan discusses the 5-year results.
Dr. Jordan discusses the 5-year...
07/01/2024
Vascular Disease Management
Video
Reducing Air Emboli in TEVAR: Making a Measurable Difference Through Recommended Use
03/01/2024
Watch this video on advancing care while minimizing air using unique TEVAR systems.
Watch this video on advancing care while minimizing air using unique TEVAR systems.
Watch this video on advancing...
03/01/2024
Vascular Disease Management
Dr Joseph Lombardi
ISET 2024
Type B Aortic Dissections: An Update on When and How to Treat
02/29/2024

Joseph Lombardi, MD, FACS
Cooper Medical School of Rowan University, Camden, New Jersey

Joseph Lombardi, MD, FACS Cooper Medi...
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon Dr. Joseph Lombardi discusses his presentation on type B aortic dissections at ISET 2024.
In this video, vascular surgeon...
02/29/2024
Vascular Disease Management
Video
A.L.W.A.Y.S. Provides a Simple Way to Ensure Key Patient Considerations Are Included in Hypogastric Preservation Decisions
02/01/2024
Watch the video to learn a simple way to ensure key patient considerations are included in hypogastric preservation decisions.
Watch the video to learn a simple way to ensure key patient considerations are included in hypogastric preservation decisions.
Watch the video to learn a...
02/01/2024
Vascular Disease Management
Video
7 Years Post-Treatment: Sharif Ellozy, MD, Talks About Common Iliac Aneurysm Treatment Considerations Specific to a Patient's Active Lifestyle
01/01/2024
Sharif Ellozy, MD
In this video, Dr. Sharif Ellozy and his patient discuss common iliac aneurysm treatment considerations that are specific to an active lifestyle.
In this video, Dr. Sharif Ellozy and his patient discuss common iliac aneurysm treatment considerations that are specific to an active lifestyle.
In this video, Dr. Sharif...
01/01/2024
Vascular Disease Management
Video
Ross Milner, MD Discusses GREAT: The Value of the Registry Based on Real-World Data
12/01/2023
Ross Milner, MD
In this video, vascular surgeon Dr. Ross Milner discusses the GREAT Registry.
In this video, vascular surgeon Dr. Ross Milner discusses the GREAT Registry.
In this video, vascular surgeon...
12/01/2023
Vascular Disease Management
Video
How Materials Science and Unique Design Features Address the Demands of TEVAR
11/01/2023

Gore Medical 

Gore Medical 
In this video, learn how the Gore TAG conformable stent graft is designed to address the demands of TEVAR.
In this video, learn how the Gore TAG conformable stent graft is designed to address the demands of TEVAR.
In this video, learn how the...
11/01/2023
Vascular Disease Management
Video
Darren Schneider, MD, Reviews Key Outcomes and Implications of 5-Year IDE Data for Iliac Branch Device
10/01/2023
Darren Schneider, MD
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider...
10/01/2023
Vascular Disease Management
Dr Setayesh Sotoudehnia
Interview
Making the Impossible Possible: MR-Guided Interventional Oncology
03/27/2025
Setayesh Sotoudehnia, MD
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh...
03/27/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Dr Dania Daye
ISET 2025
AI Governance in Procedural Practices: Who and How to Decide What Algorithms to Implement
03/24/2025
Dania Daye, MD, PhD
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses...
03/24/2025
Vascular Disease Management
Dr William Gray
ISET 2025
The Next Generation of Radiation Protection Solutions: The Dynamic SMART Shield
03/21/2025
William A. Gray, MD, FACC, FSCAI; Ripal T. Gandhi, MD, FSIR, FSVM
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD,...
03/21/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Sanjay Misra
ISET 2025
Present and Future Applications of AI in Vascular Therapy
03/20/2025
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional...
03/20/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management

Presentations

Chiara Lomazzi and Santi Trimarchi
LINC 2025
10-Year Results of the GREAT Registry: Lessons Learned From More Than 30 Publications
01/29/2025
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara Lomazzi, MD, presented the aims of the GREAT Registry, relaying its contemporary real-world data on aortic endografts in the treatment of multiple aortic pathologies.
Santi Trimarchi, MD,and Chiara...
01/29/2025
Vascular Disease Management
Dr Tsilimparis
LINC 2024
Physician-modified Endografts on Trial
05/30/2024

Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany

Nikolaos Tsilimparis, MD University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified...
05/30/2024
Vascular Disease Management
Dr Donas
LINC 2023
EnChEVAR: A Force for Standardization
06/08/2023
Konstantinos Donas, MD
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’...
06/08/2023
Vascular Disease Management
Dr Verhagen
LINC 2023
Trial Set to ADVANCE Knowledge in Sac Regression
06/07/2023
Hence Verhagen, MD
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of...
06/07/2023
Vascular Disease Management
Varcoe ISET 2023 EVAR Table
ISET 2023
A Direct Comparison of Long-Term Survival for Major Contemporary EVAR Devices Using Big Data and Linkage Techniques
01/18/2023
Amanda Wright Harvey; Ramon L. Varcoe, MBBS, MS, PhD
This study aimed to use linked clinical registries and administrative data to investigate the primary endpoint—differences in long-term all-cause mortality between contemporary EVAR stent-graft devices.
This study aimed to use linked clinical registries and administrative data to investigate the primary endpoint—differences in long-term all-cause mortality between contemporary EVAR stent-graft devices.
This study aimed to use linked...
01/18/2023
Vascular Disease Management
Dr Kracjer
ISET 2023
Large Vessel Closure: Where Do We Go From Here?
01/17/2023
Zvonomir Kracjer, MD, FACC
A session on large vessel closure was presented by Dr. Zvonomir Kracjer, who began with a review of large vessel closure devices (VCDs) approved for clinical use in the United States,
A session on large vessel closure was presented by Dr. Zvonomir Kracjer, who began with a review of large vessel closure devices (VCDs) approved for clinical use in the United States,
A session on large vessel...
01/17/2023
Vascular Disease Management
Dr Schermerhorn
Iset 2023
Sac Shrinkage in EVAR: How Important Is It?
01/17/2023
Marc Schermerhorn, MD
Dr. Marc Schermerhorn from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, Massachusetts, gave a presentation on sac shrinkage in endovascular aneurysm repair.
Dr. Marc Schermerhorn from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston, Massachusetts, gave a presentation on sac shrinkage in endovascular aneurysm repair.
Dr. Marc Schermerhorn from...
01/17/2023
Vascular Disease Management
Dr Angle
ISET 2023
Managing Branch Vessels in Acute Dissections
01/17/2023
John Fritz Angle, MD
Dr. John Fritz Angle of the University of Virginia in Charlottesville provided an overview on managing branch vessels in acute dissections.
Dr. John Fritz Angle of the University of Virginia in Charlottesville provided an overview on managing branch vessels in acute dissections.
Dr. John Fritz Angle of the...
01/17/2023
Vascular Disease Management
Dr Lombardi
ISET 2023
Type B Aortic Dissections: When to Intervene
01/17/2023
Joseph V. Lombardi, MD, FACS
During Tuesday’s Aortic Updates session, Dr. Joseph Lombardi presented an overview of intervention for type B aortic dissections.
During Tuesday’s Aortic Updates session, Dr. Joseph Lombardi presented an overview of intervention for type B aortic dissections.
During Tuesday’s Aortic Updates...
01/17/2023
Vascular Disease Management
Dr Arko
ISET 2023
Aorto-Iliac Disease: Update on Treatment Options and Data
01/16/2023
Frank Arko, III, MD
Dr. Frank Arko began his presentation on aorto-iliac disease by discussing the role of endovascular therapy in TASC II C and D inflow disease.
Dr. Frank Arko began his presentation on aorto-iliac disease by discussing the role of endovascular therapy in TASC II C and D inflow disease.
Dr. Frank Arko began his...
01/16/2023
Vascular Disease Management
Dr Brodmann
ISET 2025
Current State of Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
02/04/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented...
02/04/2025
Vascular Disease Management
Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Dr Korngold
ISET 2025
An Industry Perspective on the Carotid Space
02/03/2025
Ethan C. Korngold, MD
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief...
02/03/2025
Vascular Disease Management
Dr Yeung
ISET 2025
The Treatment of PAD and the Role of AI
02/03/2025
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from...
02/03/2025
Vascular Disease Management
Dr AbuRahma
ISET 2025
Natural History/Late Neuro Events of Asymptomatic vs. Symptomatic Subclavian Steal as Detected by Duplex Ultrasound
02/02/2025
Vascular surgeon Ali F. AbuRahma, MD, presented on the topic of late neuro events of asymptomatic vs subclavian steal syndrome.
Vascular surgeon Ali F. AbuRahma, MD, presented on the topic of late neuro events of asymptomatic vs subclavian steal syndrome.
Vascular surgeon Ali F....
02/02/2025
Vascular Disease Management
Dr Pellerito
ISET 2025
Renal and Mesenteric Pathologies
02/02/2025
At ISET 2024, John S. Pellerito, MD, vice chair of radiology at the Zucker School of Medicine, Northwell Health, delivered an in-depth presentation on renal and mesenteric vascular pathologies.
At ISET 2024, John S. Pellerito, MD, vice chair of radiology at the Zucker School of Medicine, Northwell Health, delivered an in-depth presentation on renal and mesenteric vascular pathologies.
At ISET 2024, John S. Pellerito,...
02/02/2025
Vascular Disease Management
Dr Bauer
ISET 2025
The Role of Vascular Nurses and Advanced Practice Providers in Patient Selection and Perioperative Care
02/02/2025
Karen Bauer, DNP, APRN-FNP, CWS, DAPWCA, NP-C
Karen Bauer, DNP, CWS, FAAWC, presented a session on the critical role that vascular nurses and advanced practice providers (APPs) play in patient selection, perioperative care, and overall vascular disease management.
Karen Bauer, DNP, CWS, FAAWC, presented a session on the critical role that vascular nurses and advanced practice providers (APPs) play in patient selection, perioperative care, and overall vascular disease management.
Karen Bauer, DNP, CWS, FAAWC,...
02/02/2025
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kandzari
ISET 2025
Will Renal Denervation Have an Important Role in the Treatment of Hypertension?
01/31/2025
David E. Kandzari, MD
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
David E. Kandzari, MD, FACC,...
01/31/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management
AAA Endoprosthesis
First Commercial Implant of the Gore® Excluder® Conformable AAA Endoprosthesis With Active Control System in Canada
01/27/2025
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree of control and conformability FLAGSTAFF, Ariz. (January 10, 2025) — W. L. Gore & Associates Medical Products (Gore) today announced the first commercial use of the GORE® EXCLUDER® Conformable AAA...
Bringing physicians a new degree...
01/27/2025
Vascular Disease Management
News
Echo IQ Signs Integration Agreement With Flagship US Hospital
12/12/2024
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the completion of a successful trial of EchoSolv-AS at Beth Israel in September 2024, in which BIDMC researchers validated the technology’s key performance metrics.
The integration follows the...
12/12/2024
Vascular Disease Management
Bridging Stent for FEVAR
World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation
12/02/2024
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024...
12/02/2024
Vascular Disease Management
News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Embolic Protection for TAVR
EMBLOK Announces Enrollment of 50th Patient in Clinical Trial for Emblok™ Embolic Protection System for use in TAVR Procedures, Appoints Scientific and Strategic Advisory Board
10/08/2024
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity Tampa, FL – October 8, 2024 – EMBLOK™ (emblok.com), a privately held medical...
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity Tampa, FL – October 8, 2024 – EMBLOK™ (emblok.com), a privately held medical...
Medical device company marks...
10/08/2024
Vascular Disease Management
thoracic endovascular aortic repair
First Commercial Implant of the GORE® TAG® Thoracic Branch Endoprosthesis in Canada
06/28/2024
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible,...
06/28/2024
Vascular Disease Management
AAA Endoprosthesis
Now Indicated for AAA Patients With Highly Angulated Necks
05/01/2024

Gore Media Update

Gore Media Update
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30,...
05/01/2024
Vascular Disease Management
News

First European Implantation of GORE®TAG® Thoracic Branch Endoprosthesis
02/01/2024
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment. PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment. PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies...
02/01/2024
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use